home / stock / nbix / nbix short
Short Information | Neurocrine Biosciences Inc. (NASDAQ:NBIX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,354,002 |
Total Actual Volume | 15,564,637 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 117,700 |
Average Short Percentage | 14.80% |
Is there a NBIX Short Squeeze or Breakout about to happen?
See the NBIX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-17-2024 | $141.97 | $142.29 | $142.86 | $140.51 | 641,937 | 142,249 | 22.16% |
05-16-2024 | $141.17 | $141.91 | $142.3 | $140.17 | 670,978 | 126,407 | 18.84% |
05-15-2024 | $138.9 | $142 | $142.19 | $138.9 | 684,685 | 157,801 | 23.05% |
05-14-2024 | $137.12 | $138.48 | $138.73 | $134.79 | 622,237 | 76,830 | 12.35% |
05-13-2024 | $138 | $136.15 | $138.685 | $135.23 | 712,827 | 64,398 | 9.03% |
05-10-2024 | $140 | $136.7 | $140.9999 | $136.1 | 679,327 | 58,585 | 8.62% |
05-09-2024 | $139.36 | $139.66 | $140.71 | $138.95 | 479,494 | 58,454 | 12.19% |
05-08-2024 | $143.5 | $139.02 | $143.54 | $138.15 | 653,578 | 68,616 | 10.5% |
05-07-2024 | $142.03 | $143.19 | $143.86 | $140.9 | 667,258 | 86,475 | 12.96% |
05-06-2024 | $140.55 | $141.71 | $143.57 | $140.55 | 483,775 | 64,112 | 13.25% |
05-03-2024 | $140.9 | $140.71 | $141.88 | $139.23 | 616,567 | 93,270 | 15.13% |
05-02-2024 | $143.79 | $139.83 | $144.09 | $139.63 | 882,407 | 138,327 | 15.68% |
05-01-2024 | $140.18 | $143.03 | $145.22 | $136.01 | 1,601,873 | 327,164 | 20.42% |
04-30-2024 | $138.07 | $137.54 | $140.47 | $137.34 | 966,534 | 198,937 | 20.58% |
04-29-2024 | $136.05 | $138.89 | $139.37 | $136.05 | 681,748 | 97,056 | 14.24% |
04-26-2024 | $137.47 | $135.99 | $138.63 | $135.17 | 717,575 | 68,103 | 9.49% |
04-25-2024 | $139.37 | $137.76 | $139.37 | $136.06 | 735,781 | 85,566 | 11.63% |
04-24-2024 | $140.89 | $138.97 | $144.7 | $138.01 | 883,288 | 94,168 | 10.66% |
04-23-2024 | $141 | $140.09 | $145 | $139.22 | 1,607,701 | 226,173 | 14.07% |
04-22-2024 | $132.48 | $133.66 | $134.1798 | $131.7949 | 575,067 | 121,311 | 21.1% |
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
NASDAQ Market:
Neurocrine Biosciences Inc. Website:
Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024 PR Newswire - CAHtalyst™ Phase 3 Baseline Characteristics Highlight Limitatio...
2024-05-13 17:00:06 ET Cory Kasimov from Evercore ISI issued a price target of $175.00 for NBIX on 2024-05-13 16:13:00. The adjusted price target was set to $175.00. At the time of the announcement, NBIX was trading at $136.15. The overall price target consensus is at $1...
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024 PR Newswire CAHtalyst™ Study Baseline Characteristics Highlight the Need for New Treatment Options to Reduce...